Are you a new member? Sign up now
Login area
| Sign up
close
REVOLADE - 50mg - 28
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BX05 | B | Eltrombopag Olamine - 50mg | 11624 | 21623/1 | REVOLADE | 50mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 2,350,571 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 05/02/20 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BX05 | B | Eltrombopag Olamine - 50mg | 8789 | 120516/1 | REVOLADE | 50mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Siegfried Barbera SL | Spain | 2,350,571 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 05/02/20 | |
| B02BX05 | B | Eltrombopag Olamine - 50mg | 8789/945 | 120516/1 | REVOLADE | 50mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Siegfried Barbera SL | Spain | 143,306,217 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 05/02/20 | 0 |
| B02BX05 | B | Eltrombopag Olamine - 50mg | 11624/945 | 21623/1 | REVOLADE | 50mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 143,306,217 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 05/02/20 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024